nursing notes

Post on 18-Jul-2016

77 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

DESCRIPTION

notes for nursing

TRANSCRIPT

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injection

Warfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K). Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild

thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline

hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on

HeparinAnticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)

Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of enoxaparin by slow IV injection

Warfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K). Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to

increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs:

Unfractionated heparinDoes not dissolve existing thrombus, but prevents the extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on

anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline

information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injection

Warfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K). Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

Anticoagulation therapy No IM drugs duringAnticoagulants are antithrombotic drugs\

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count before starting patients on anticoagulant therapy

Types of anticoagulant drugs: Unfractionated heparinDoes not dissolve existing thrombus, but prevents the

extension of the thrombus and more thrombi from forming. May cause mild thrombocytopenia (Appears on 4th day of therapy and resolves with continued therapy. Heparin-induced thrombocytopenia occurs on 8th day and may lead to increased resistance to heparin therapy. Protamine sulfate is antidote. Due to short half life overdose can be treated by withdrawing the drug

Low-molecular-weight heparin (Enoxaparin, Dalteparin, and Tinzaparin)Enoxaparin (Lovenox) Antidote Protamine sulfate 1mg for each mg of

enoxaparin by slow IV injectionWarfarin (Coumadin)Antidote Vitamin K (Avoid foods high in vitamin K).

Takes 3-5 days to reach effective levels; Usually begun while patient still on Heparin

top related